Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Wonder Book, Frederick, MD, Estados Unidos de America
EUR 7,02
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: Very Good. Very Good condition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp. Bundled media such as CDs, DVDs, floppy disks or access codes may not be included.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 71,26
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 73,59
Cantidad disponible: 2 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 69,63
Cantidad disponible: 2 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 74,57
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 71,39
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por National Academies Press, US, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 85,12
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: New. December 13, 2002, the president of the United States announced that smallpox vaccination would be offered to some categories of civilians and administered to members of the military and government representatives in high-risk areas of the world. The events that precipitated that historic announcement included a series of terrorist attacks during the 1990s, which culminated in the catastrophic events of 2001. Although preparedness for deliberate attacks with biologic weapons was already the subject of much public health planning, meetings, and publications as the twentieth century neared its end, the events of 2001 led to a steep rise in bioterrorism-related government policies and funding, and in state and local preparedness activities, for example, in public health, health care, and the emergency response and public safety communities. The national smallpox vaccination program is but one of many efforts to improve readiness to respond to deliberate releases of biologic agents.The Institute of Medicine (IOM) Committee on Smallpox Vaccination Program Implementation was convened in October 2002 at the request of the Centers for Disease Control and Prevention (CDC), the federal agency charged with implementing the government's policy of providing smallpox vaccine first to public health and health care workers on response teams, then to all interested health care workers and other first responders, and finally to members of the general public who might insist on receiving the vaccine. The committee was charged with providing "advice to the CDC and the program investigators on selected aspects of the smallpox program implementation and evaluation." The committee met six times over 19 months and wrote a series of brief "letter" reports.The Smallpox Vaccination Program: Public Health in an Age of Terrorism constitutes the committee's seventh and final report, and the committee hopes that it will fulfill three purposes: 1) To serve as an archival document that brings together the six reports addressed to Julie Gerberding, director of CDC, and previously released on line and as short, unbound papers; 2) To serve as a historical document that summarizes milestones in the smallpox vaccination program, and; 3) To comment on the achievement of overall goals of the smallpox vaccination program (in accordance with the last item in the charge), including lessons learned from the program.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 69,62
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press, US, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Rarewaves USA, OSWEGO, IL, Estados Unidos de America
EUR 88,03
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: New. December 13, 2002, the president of the United States announced that smallpox vaccination would be offered to some categories of civilians and administered to members of the military and government representatives in high-risk areas of the world. The events that precipitated that historic announcement included a series of terrorist attacks during the 1990s, which culminated in the catastrophic events of 2001. Although preparedness for deliberate attacks with biologic weapons was already the subject of much public health planning, meetings, and publications as the twentieth century neared its end, the events of 2001 led to a steep rise in bioterrorism-related government policies and funding, and in state and local preparedness activities, for example, in public health, health care, and the emergency response and public safety communities. The national smallpox vaccination program is but one of many efforts to improve readiness to respond to deliberate releases of biologic agents.The Institute of Medicine (IOM) Committee on Smallpox Vaccination Program Implementation was convened in October 2002 at the request of the Centers for Disease Control and Prevention (CDC), the federal agency charged with implementing the government's policy of providing smallpox vaccine first to public health and health care workers on response teams, then to all interested health care workers and other first responders, and finally to members of the general public who might insist on receiving the vaccine. The committee was charged with providing "advice to the CDC and the program investigators on selected aspects of the smallpox program implementation and evaluation." The committee met six times over 19 months and wrote a series of brief "letter" reports.The Smallpox Vaccination Program: Public Health in an Age of Terrorism constitutes the committee's seventh and final report, and the committee hopes that it will fulfill three purposes: 1) To serve as an archival document that brings together the six reports addressed to Julie Gerberding, director of CDC, and previously released on line and as short, unbound papers; 2) To serve as a historical document that summarizes milestones in the smallpox vaccination program, and; 3) To comment on the achievement of overall goals of the smallpox vaccination program (in accordance with the last item in the charge), including lessons learned from the program.
Idioma: Inglés
Publicado por National Academies Press, Washington, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Original o primera edición
EUR 90,35
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. December 13, 2002, the president of the United States announced that smallpox vaccination would be offered to some categories of civilians and administered to members of the military and government representatives in high-risk areas of the world. The events that precipitated that historic announcement included a series of terrorist attacks during the 1990s, which culminated in the catastrophic events of 2001. Although preparedness for deliberate attacks with biologic weapons was already the subject of much public health planning, meetings, and publications as the twentieth century neared its end, the events of 2001 led to a steep rise in bioterrorism-related government policies and funding, and in state and local preparedness activities, for example, in public health, health care, and the emergency response and public safety communities. The national smallpox vaccination program is but one of many efforts to improve readiness to respond to deliberate releases of biologic agents.The Institute of Medicine (IOM) Committee on Smallpox Vaccination Program Implementation was convened in October 2002 at the request of the Centers for Disease Control and Prevention (CDC), the federal agency charged with implementing the government's policy of providing smallpox vaccine first to public health and health care workers on response teams, then to all interested health care workers and other first responders, and finally to members of the general public who might insist on receiving the vaccine. The committee was charged with providing "advice to the CDC and the program investigators on selected aspects of the smallpox program implementation and evaluation." The committee met six times over 19 months and wrote a series of brief "letter" reports.The Smallpox Vaccination Program: Public Health in an Age of Terrorism constitutes the committee's seventh and final report, and the committee hopes that it will fulfill three purposes: 1) To serve as an archival document that brings together the six reports addressed to Julie Gerberding, director of CDC, and previously released on line and as short, unbound papers; 2) To serve as a historical document that summarizes milestones in the smallpox vaccination program, and; 3) To comment on the achievement of overall goals of the smallpox vaccination program (in accordance with the last item in the charge), including lessons learned from the program. The Smallpox Vaccination Programme: Public Health in an Age of Terrorism Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 79,10
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New. The Smallpox Vaccination Programme: Public Health in an Age of Terrorism Editor(s): Baciu, Alina; Anason, Andrea Pernack; Stratton, Kathleen; Strom, Brian L. Num Pages: 392 pages. BIC Classification: MBN. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 21. Weight in Grams: 635. . 2005. Paperback. . . . .
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 76,40
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 85,47
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 1st edition. 370 pages. 9.25x6.00x1.00 inches. In Stock.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 82,12
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback / softback. Condición: New. New copy - Usually dispatched within 3 working days.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 96,53
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New. The Smallpox Vaccination Programme: Public Health in an Age of Terrorism Editor(s): Baciu, Alina; Anason, Andrea Pernack; Stratton, Kathleen; Strom, Brian L. Num Pages: 392 pages. BIC Classification: MBN. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 21. Weight in Grams: 635. . 2005. Paperback. . . . . Books ship from the US and Ireland.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Speedyhen, Hertfordshire, Reino Unido
EUR 60,59
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: NEW.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 110,49
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Brand New. 1st edition. 370 pages. 9.25x6.00x1.00 inches. In Stock.
Librería: moluna, Greven, Alemania
EUR 78,57
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New. The Smallpox Vaccination Programme: Public Health in an Age of TerrorismÜber den AutorCommittee on Smallpox Vaccination Program Implementation, Alina Baciu, Andrea Pernack Anason, Kathleen Stratton, and Brian Strom, Editors.
Idioma: Inglés
Publicado por National Academies Press, US, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Rarewaves USA United, OSWEGO, IL, Estados Unidos de America
EUR 89,50
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: New. December 13, 2002, the president of the United States announced that smallpox vaccination would be offered to some categories of civilians and administered to members of the military and government representatives in high-risk areas of the world. The events that precipitated that historic announcement included a series of terrorist attacks during the 1990s, which culminated in the catastrophic events of 2001. Although preparedness for deliberate attacks with biologic weapons was already the subject of much public health planning, meetings, and publications as the twentieth century neared its end, the events of 2001 led to a steep rise in bioterrorism-related government policies and funding, and in state and local preparedness activities, for example, in public health, health care, and the emergency response and public safety communities. The national smallpox vaccination program is but one of many efforts to improve readiness to respond to deliberate releases of biologic agents.The Institute of Medicine (IOM) Committee on Smallpox Vaccination Program Implementation was convened in October 2002 at the request of the Centers for Disease Control and Prevention (CDC), the federal agency charged with implementing the government's policy of providing smallpox vaccine first to public health and health care workers on response teams, then to all interested health care workers and other first responders, and finally to members of the general public who might insist on receiving the vaccine. The committee was charged with providing "advice to the CDC and the program investigators on selected aspects of the smallpox program implementation and evaluation." The committee met six times over 19 months and wrote a series of brief "letter" reports.The Smallpox Vaccination Program: Public Health in an Age of Terrorism constitutes the committee's seventh and final report, and the committee hopes that it will fulfill three purposes: 1) To serve as an archival document that brings together the six reports addressed to Julie Gerberding, director of CDC, and previously released on line and as short, unbound papers; 2) To serve as a historical document that summarizes milestones in the smallpox vaccination program, and; 3) To comment on the achievement of overall goals of the smallpox vaccination program (in accordance with the last item in the charge), including lessons learned from the program.
Idioma: Inglés
Publicado por National Academies Press Okt 2005, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 88,55
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware - December 13, 2002, the president of the United States announced that smallpox vaccination would be offered to some categories of civilians and administered to members of the military and government representatives in high-risk areas of the world. The events that precipitated that historic announcement included a series of terrorist attacks during the 1990s, which culminated in the catastrophic events of 2001. Although preparedness for deliberate attacks with biologic weapons was already the subject of much public health planning, meetings, and publications as the twentieth century neared its end, the events of 2001 led to a steep rise in bioterrorism-related government policies and funding, and in state and local preparedness activities, for example, in public health, health care, and the emergency response and public safety communities. The national smallpox vaccination program is but one of many efforts to improve readiness to respond to deliberate releases of biologic agents. The Institute of Medicine (IOM) Committee on Smallpox Vaccination Program Implementation was convened in October 2002 at the request of the Centers for Disease Control and Prevention (CDC), the federal agency charged with implementing the government's policy of providing smallpox vaccine first to public health and health care workers on response teams, then to all interested health care workers and other first responders, and finally to members of the general public who might insist on receiving the vaccine. The committee was charged with providing 'advice to the CDC and the program investigators on selected aspects of the smallpox program implementation and evaluation.' The committee met six times over 19 months and wrote a series of brief 'letter' reports. The Smallpox Vaccination Program: Public Health in an Age of Terrorism constitutes the committee's seventh and final report, and the committee hopes that it will fulfill three purposes: 1) To serve as an archival document that brings together the six reports addressed to Julie Gerberding, director of CDC, and previously released on line and as short, unbound papers; 2) To serve as a historical document that summarizes milestones in the smallpox vaccination program, and; 3) To comment on the achievement of overall goals of the smallpox vaccination program (in accordance with the last item in the charge), including lessons learned from the program.
Idioma: Inglés
Publicado por National Academies Press, US, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: Rarewaves.com UK, London, Reino Unido
EUR 78,92
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: New. December 13, 2002, the president of the United States announced that smallpox vaccination would be offered to some categories of civilians and administered to members of the military and government representatives in high-risk areas of the world. The events that precipitated that historic announcement included a series of terrorist attacks during the 1990s, which culminated in the catastrophic events of 2001. Although preparedness for deliberate attacks with biologic weapons was already the subject of much public health planning, meetings, and publications as the twentieth century neared its end, the events of 2001 led to a steep rise in bioterrorism-related government policies and funding, and in state and local preparedness activities, for example, in public health, health care, and the emergency response and public safety communities. The national smallpox vaccination program is but one of many efforts to improve readiness to respond to deliberate releases of biologic agents.The Institute of Medicine (IOM) Committee on Smallpox Vaccination Program Implementation was convened in October 2002 at the request of the Centers for Disease Control and Prevention (CDC), the federal agency charged with implementing the government's policy of providing smallpox vaccine first to public health and health care workers on response teams, then to all interested health care workers and other first responders, and finally to members of the general public who might insist on receiving the vaccine. The committee was charged with providing "advice to the CDC and the program investigators on selected aspects of the smallpox program implementation and evaluation." The committee met six times over 19 months and wrote a series of brief "letter" reports.The Smallpox Vaccination Program: Public Health in an Age of Terrorism constitutes the committee's seventh and final report, and the committee hopes that it will fulfill three purposes: 1) To serve as an archival document that brings together the six reports addressed to Julie Gerberding, director of CDC, and previously released on line and as short, unbound papers; 2) To serve as a historical document that summarizes milestones in the smallpox vaccination program, and; 3) To comment on the achievement of overall goals of the smallpox vaccination program (in accordance with the last item in the charge), including lessons learned from the program.
Idioma: Inglés
Publicado por National Academies Press, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: preigu, Osnabrück, Alemania
EUR 87,65
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. The Smallpox Vaccination Program | Public Health in an Age of Terrorism | Board on Health Promotion and Disease Prevention (u. a.) | Taschenbuch | Kartoniert / Broschiert | Englisch | 2005 | National Academies Press | EAN 9780309095921 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
Idioma: Inglés
Publicado por National Academies Press, Washington, 2005
ISBN 10: 0309095921 ISBN 13: 9780309095921
Librería: AussieBookSeller, Truganina, VIC, Australia
Original o primera edición
EUR 138,39
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. December 13, 2002, the president of the United States announced that smallpox vaccination would be offered to some categories of civilians and administered to members of the military and government representatives in high-risk areas of the world. The events that precipitated that historic announcement included a series of terrorist attacks during the 1990s, which culminated in the catastrophic events of 2001. Although preparedness for deliberate attacks with biologic weapons was already the subject of much public health planning, meetings, and publications as the twentieth century neared its end, the events of 2001 led to a steep rise in bioterrorism-related government policies and funding, and in state and local preparedness activities, for example, in public health, health care, and the emergency response and public safety communities. The national smallpox vaccination program is but one of many efforts to improve readiness to respond to deliberate releases of biologic agents.The Institute of Medicine (IOM) Committee on Smallpox Vaccination Program Implementation was convened in October 2002 at the request of the Centers for Disease Control and Prevention (CDC), the federal agency charged with implementing the government's policy of providing smallpox vaccine first to public health and health care workers on response teams, then to all interested health care workers and other first responders, and finally to members of the general public who might insist on receiving the vaccine. The committee was charged with providing "advice to the CDC and the program investigators on selected aspects of the smallpox program implementation and evaluation." The committee met six times over 19 months and wrote a series of brief "letter" reports.The Smallpox Vaccination Program: Public Health in an Age of Terrorism constitutes the committee's seventh and final report, and the committee hopes that it will fulfill three purposes: 1) To serve as an archival document that brings together the six reports addressed to Julie Gerberding, director of CDC, and previously released on line and as short, unbound papers; 2) To serve as a historical document that summarizes milestones in the smallpox vaccination program, and; 3) To comment on the achievement of overall goals of the smallpox vaccination program (in accordance with the last item in the charge), including lessons learned from the program. The Smallpox Vaccination Programme: Public Health in an Age of Terrorism Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.